Cite
HARVARD Citation
Katz, J. et al. (2022). A Phase 1 study of GDC‐0134, a dual leucine zipper kinase inhibitor, in ALS. Annals of clinical and translational neurology. 9 (1), pp. 50-66. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Katz, J. et al. (2022). A Phase 1 study of GDC‐0134, a dual leucine zipper kinase inhibitor, in ALS. Annals of clinical and translational neurology. 9 (1), pp. 50-66. [Online].